Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells:: possible roles of interferon α, tumor necrosis factor α and transforming growth factor β in Mn-SOD induction by polysaccharide K

被引:17
作者
Habelhah, H
Okada, F
Nakai, K
Choi, SK
Hamada, J
Kobayashi, M
Hosokawa, M
机构
[1] Hokkaido Univ, Sch Med, Inst Canc,Lab Pathol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Hokkaido Univ, Sch Med, Inst Canc,Div Cell Biol, Kita Ku, Sapporo, Hokkaido 0608638, Japan
关键词
tumor progression; PSK; TGF beta; IFN gamma; Mn-SOD;
D O I
10.1007/s002620050495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously we reported the malignant progression of QR-32, a regressor-type tumor clone, following co-implantation with foreign bodies (gelatin sponge or plastic plate) in normal syngeneic C57BL/6 mice. We also reported that the progression of QR-32 cells by a gelatin sponge was significantly inhibited in the mice administered polysaccharide K (PSK) and that PSK induced an increase of radical scavengers, especially manganese superoxide dismutase (Mn-SOD), locally at the site of tumor tissues. In this study, to reveal the possible mechanism by which PSK induced Mn-SOD in the tumor tissues, we examined the mRNA expression and protein levels of inflammatory cytokines in the tissues. We found that mRNAs of tumor necrosis factor alpha (TNF alpha) and interleukin-1 alpha (IL-1 alpha) were considerably expressed in both PSK-treated and phosphate-buffered-saline-treated tumors, and that the mRNA expression and protein level of interferon gamma (IFN gamma) increased in the tumor tissues treated with PSK. In vitro treatment of QR-32 cells with IFN gamma did not significantly increase the production of Mn-SOD; however, the combination of IFN gamma with TNF alpha increased the Mn-SOD production more effectively than did any of the cytokines used singly. Furthermore, we observed the down-regulation of the mRNA expression and protein level of transforming growth factor beta (TGF beta) in the tumor tissues treated with PSK, and that in vitro treatment of QR-32 cells with TGF beta decreased the production of Mn-SOD. These results suggest that PSK suppresses the progression of QR-32 cells by increasing Mn-SOD via the modulation of inflammatory cytokines; that is, by decreasing TGF-beta and increasing IFN-gamma.
引用
收藏
页码:338 / 344
页数:7
相关论文
共 38 条
[21]   Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant [J].
Kuramitsu, Y ;
Nishibe, M ;
Kobayashi, M ;
Togashi, Y ;
Yuan, L ;
Takizawa, M ;
Okada, F ;
Hosokawa, M .
BRITISH JOURNAL OF CANCER, 1996, 74 (02) :274-279
[22]   Genetic analysis of ageing: Role of oxidative damage and environmental stresses [J].
Martin, GM ;
Austad, SN ;
Johnson, TE .
NATURE GENETICS, 1996, 13 (01) :25-34
[23]  
Matsunaga K, 1996, INVAS METAST, V16, P27
[24]   COMBINED THERAPEUTIC EFFECTS OF CONVENTIONAL AGENTS AND AN IMMUNOMODULATOR, PSK, ON RAT PROSTATIC ADENOCARCINOMA [J].
MICKEY, DD ;
CARVALHO, L ;
FOULKES, K .
JOURNAL OF UROLOGY, 1989, 142 (06) :1594-1598
[25]  
NAKAI K, 1996, P 55 ANN M JPN CANC, P159
[26]   EFFICACY OF IMMUNOCHEMOTHERAPY AS ADJUVANT TREATMENT AFTER CURATIVE RESECTION OF GASTRIC-CANCER [J].
NAKAZATO, H ;
KOIKE, A ;
SAJI, S ;
OGAWA, N ;
SAKAMOTO, J .
LANCET, 1994, 343 (8906) :1122-1126
[27]  
NOGUCHI K, 1995, ANTICANCER RES, V15, P255
[28]  
OBERLEY LW, 1979, CANCER RES, V39, P1141
[29]  
Oberley TD, 1997, HISTOL HISTOPATHOL, V12, P525
[30]   REGRESSION MECHANISMS OF MOUSE FIBROSARCOMA CELLS AFTER INVITRO EXPOSURE TO QUERCETIN - DIMINUTION OF TUMORIGENICITY WITH A CORRESPONDING DECREASE IN THE PRODUCTION OF PROSTAGLANDIN-E2 [J].
OKADA, F ;
HOSOKAWA, M ;
HASEGAWA, J ;
ISHIKAWA, M ;
CHIBA, I ;
NAKAMURA, Y ;
KOBAYASHI, H .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (06) :358-364